Core Viewpoint - The announcement from HeartTech Medical (02291) indicates that its major shareholder, Lepu Medical (listed on Shenzhen Stock Exchange, stock code: 300003), will sell a total of 11.14 million H-shares at a price of HKD 22.79 per share, representing approximately 3.21% of the total issued shares as of the announcement date [1] Group 1 - Lepu Medical will continue to hold 268.86 million shares post-sale, which includes 266.06 million shares directly held and 2.8 million shares held by its subsidiary, accounting for about 77.54% of the total issued share capital as of the announcement date [1] - The sale is intended to enhance the liquidity of HeartTech Medical's stock, reflecting Lepu Medical's confidence in the company's business operations [1]